E-LIB Suche - Ergebnisse für: Uzunoglu, Sernaz

1

Comparison of real-life data from patients with NGS panel n..:

Gökyer, Ali ; Küçükarda, Ahmet ; Köstek, Osman...
Tumori Journal. 108 (2021) 2 - p. 141-146 , 2021

Link: https://doi.org/10.1177/..

2

Prognostic nutritional index and its dynamics after curativ..:

Küçükarda, Ahmet ; Erdoğan, Bülent ; Gökyer, Ali...
Supportive Care in Cancer. 30 (2021) 3 - p. 2131-2139 , 2021

Link: https://doi.org/10.1007/..

3

Prognostic Factors for Survival in Transverse Colon Cancers:

Küçükarda, Ahmet ; Gökyer, Ali ; Sayın, Sezin...
Journal of Gastrointestinal Cancer. , 2021

Link: https://doi.org/10.1007/..

4

Contrast nephropathy in cancer patients receiving anti-VEGF..:

Gökyer, Ali ; Küçükarda, Ahmet ; Köstek, Osman...
International Journal of Clinical Oncology. 25 (2020) 10 - p. 1757-1762 , 2020

Link: https://doi.org/10.1007/..

5

Changes in skeletal muscle area and lean body mass during p..:

Köstek, Osman ; Yılmaz, Erdem ; Hacıoğlu, Muhammet Bekir...
Cancer Chemotherapy and Pharmacology. 83 (2019) 4 - p. 735-742 , 2019

Link: https://doi.org/10.1007/..

6

Overcoming the resistance in HER2(+) metastatic breast canc..:

Uzunoğlu, Sernaz
Leukemia Research. 85 (2019) - p. S15 , 2019

Link: https://doi.org/10.1016/..

7

Regorafenib or rechallenge chemotherapy: which is more effe..:

Köstek, Osman ; Hacıoğlu, Muhammet Bekir ; Sakin, Abdullah...
Cancer Chemotherapy and Pharmacology. 83 (2018) 1 - p. 115-122 , 2018

Link: https://doi.org/10.1007/..

8

A retrospective study on potential drug interactions: A sin..:

Korucu, Fatma Ceyda ; Senyigit, Ece ; Köstek, Osman...
Journal of Oncological Sciences. 4 (2018) 2 - p. 80-84 , 2018

Link: https://doi.org/10.1016/..

9

Retrospective multicenter evaluation of patients diagnosed ..:

Ercelep, Ozlem ; Topcu, Turkan Ozturk ; Bayoglu, Ibrahim Vedat...
Tumor Biology. 37 (2016) 9 - p. 12033-12038 , 2016

Link: https://doi.org/10.1007/..

10

Durable response with medroxiprogesterone acetate in metast..:

Hacioglu, Bekir Muhammet ; Kostek, Osman ; Erdogan, Bulent...
Journal of Oncological Sciences. 2 (2016) 2-3 - p. 69-70 , 2016

Link: https://doi.org/10.1016/..

11

Single-agent bevacizumab is an effective treatment in recur..:

Hacibekiroglu, Ilhan ; Kodaz, Hilmi ; Erdogan, Bulent...
Medical Oncology. 32 (2015) 2 - p. , 2015

Link: https://doi.org/10.1007/..

12

Erratum to: Single-agent bevacizumab is an effective treatm..:

Hacibekiroglu, Ilhan ; Kodaz, Hilmi ; Erdogan, Bulent...
Medical Oncology. 32 (2015) 4 - p. , 2015

Link: https://doi.org/10.1007/..

13

Increased Dose Single-agent Gemcitabine in Platinum-taxane ..:

Kodaz, Hilmi ; Hacibekiroglu, Ilhan ; Turkmen, Esma...
Tumori Journal. 101 (2015) 1 - p. 36-40 , 2015

Link: https://doi.org/10.5301/..

14

Impact of bevacizumab on survival outcomes in primary tumor..:

Kodaz, Hilmi ; Erdogan, Bulent ; Hacibekiroglu, Ilhan...
Medical Oncology. 32 (2014) 1 - p. , 2014

Link: https://doi.org/10.1007/..

15

Assessment of CA-125 area under the curve as a prognostic f..:

Uzunoglu, Sernaz ; Aybatlı, Aysun ; Kaplan, Petek Balkanlı...
Medical Oncology. 30 (2013) 1 - p. , 2013

Link: https://doi.org/10.1007/..